Showing results (321-330 of 352) with videos related to

Sort By:
Pageof 36
Infectious Diseases of Poverty|November 27, 2025
Early and sustained community engagement to reach unreached populations for malaria elimination in Lao People's Democratic RepublicSanjeev Ranjan Roy, Virasack Banouvong, Elizabeth Hoban, et al.
Open Forum Infectious Diseases|July 22, 2024
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention TrialsValeria D Cantos, Moni Neradilek, Yunda Huang, et al.
The Journal of Physical Chemistry. A|October 2, 2009
Photophysical properties of an alkyne-bridged bis(zinc porphyrin)-perylene bis(dicarboximide) derivativeSusan A Odom, Richard F Kelley, Shino Ohira, et al.
The Journal of Biological Chemistry|October 23, 2015
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey PharmacokineticsDaniela Bumbaca Yadav, Vikas K Sharma, Charles Andrew Boswell, et al.
Journal of the International AIDS Society|December 15, 2021
Condomless receptive anal intercourse is associated with markers of mucosal inflammation in a cohort of men who have sex with men in Atlanta, GeorgiaColleen F Kelley, Ilana Pollack, Rami Yacoub, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2025
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine AssociationJulia L Marcus, Andrea Weddle, Colleen F Kelley, et al.
Open Forum Infectious Diseases|December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE TrialDean Follmann, Xiaowei Wang, Lindsey R Baden, et al.
AIDS (London, England)|September 16, 2022
The association between comorbidities and coronavirus disease 2019 hospitalization among people with HIV differs by ageCaitlin A Moran, Nora T Oliver, Brittany Szabo, et al.
AIDS and Behavior|January 5, 2020
"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a MedicationIlona Fridman, Peter A Ubel, Jennifer Blumenthal-Barby, et al.
Journal of Molecular Biology|March 6, 2013
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodiesHomer Pantua, Jingyu Diao, Mark Ultsch, et al.
Pageof 36